Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 1291

Sort by

Sort Order Select

Journal Articles

Losing control to bad relatives

Vahid Afshar-Kharghan

Blood (2021) 137 (25): 3462–3463.

https://doi.org/10.1182/blood.2021011364

Published: 2021

Journal Articles

Molecular bases for the association of FHR-1 with atypical hemolytic uremic syndrome and other diseases

Héctor Martin Merinero, Marta Subías, Amaia Pereda, Elena Gómez-Rubio, Lucia Juana Lopez, Constantino Fernandez, Elena Goicoechea de Jorge, Sonsoles Martin-Santamaria, Francisco Javier Cañada, Santiago Rodríguez de Córdoba

Blood (2021) 137 (25): 3484–3494.

https://doi.org/10.1182/blood.2020010069

Published: 2021

Includes: Supplemental data

Journal Articles

Markers of complement activation in plasma during quiescent phases in patients with catastrophic antiphospholipid syndrome

Amelia Ruffatti, Marta Tonello, Paolo Macor, Antonia Calligaro, Teresa Del Ross, Maria Favaro, Virginia Lotti, Antonio Carletto, Ariela Hoxha, Domenico Biasi

Blood (2021) 137 (21): 2989–2992.

https://doi.org/10.1182/blood.2020010575

Published: 2021

Journal Articles

Eculizumab discontinuation in children and adults with atypical hemolytic-uremic syndrome: a prospective multicenter study

Blood (2021) 137 (18): 2438–2449.

https://doi.org/10.1182/blood.2020009280

Published: 2021

Includes: Supplemental data

Journal Articles

How I treat cold agglutinin disease

Sigbjørn Berentsen

Blood (2021) 137 (10): 1295–1303.

https://doi.org/10.1182/blood.2019003809

Published: 2021

Journal Articles

How I treat paroxysmal nocturnal hemoglobinuria

Robert A. Brodsky

Blood (2021) 137 (10): 1304–1309.

https://doi.org/10.1182/blood.2019003812

Published: 2021

Journal Articles

More about complement in the antiphospholipid syndrome

Sjoerd A. M. E. G. Timmermans, Jan G. M. C. Damoiseaux, Chris P. Reutelingsperger, Pieter van Paassen

Blood (2020) 136 (12): 1456–1459.

https://doi.org/10.1182/blood.2020005171

Published: 2020

Includes: Supplemental data

Journal Articles

The different flavors and splices of MCL

Oliver Weigert

Blood (2020) 136 (5): 526–527.

https://doi.org/10.1182/blood.2020005591

Published: 2020

Journal Articles

Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab

Sonata Jodele, Christopher E. Dandoy, Adam Lane, Benjamin L. Laskin, Ashley Teusink-Cross, Kasiani C. Myers, Gregory Wallace, Adam Nelson, Jack Bleesing, Ranjit S. Chima, Russel Hirsch, Thomas D. Ryan, Stefanie Benoit, Kana Mizuno, Mikako Warren, Stella M. Davies

Blood (2020) 135 (13): 1049–1057.

https://doi.org/10.1182/blood.2019004218

Published: 2020

Includes: Supplemental data

Journal Articles

Compliments to complement blockade for TA-TMA

Michael Scordo, Sergio Giralt

Blood (2020) 135 (13): 981–983.

https://doi.org/10.1182/blood.2020005040

Published: 2020

Journal Articles

A complementary new drug for PNH

Robert A. Brodsky

Blood (2020) 135 (12): 884–885.

https://doi.org/10.1182/blood.2020004959

Published: 2020

Journal Articles

The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria

Blood (2020) 135 (12): 912–920.

https://doi.org/10.1182/blood.2019003399

Published: 2020

Includes: Supplemental data

Journal Articles

“HIT”ing back against NETs

Shadi Swaidani, Keith R. McCrae

Blood (2020) 135 (10): 706–707.

https://doi.org/10.1182/blood.2019004461

Published: 2020

Journal Articles

Taken the wrong way, a complement becomes catastrophic

Nathan T. Connell

Blood (2020) 135 (4): 233–234.

https://doi.org/10.1182/blood.2019004337

Published: 2020

Journal Articles

Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS

Shruti Chaturvedi, Evan M. Braunstein, Xuan Yuan, Jia Yu, Alice Alexander, Hang Chen, Eleni Gavriilaki, Ravi Alluri, Michael B. Streiff, Michelle Petri, Mark A. Crowther, Keith R. McCrae, Robert A. Brodsky

Blood (2020) 135 (4): 239–251.

https://doi.org/10.1182/blood.2019003863

Published: 2020

Includes: Supplemental data

Journal Articles

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study

Alexander Röth, Wilma Barcellini, Shirley D'Sa, Yoshitaka Miyakawa, Catherine M Broome, Marc Michel, David J. Kuter, Bernd Jilma, Tor Henrik Anderson Tvedt, Stella Lin, Xiaoyu Jiang, Caroline Reuter, William Hobbs, Sigbjørn Berentsen

Blood (2019) 134 (Supplement_2): LBA-2.

https://doi.org/10.1182/blood-2019-132490

Published: 2019

Journal Articles

Increasing Lengths of First Complete Remission with 7+3 Induction Chemotherapy for Acute Myeloid Leukemia over the Past Four Decades: Analysis of SWOG Trial Data

Megan Othus, PhD, Guillermo Garcia-Manero, MD, John E. Godwin, MD, James K. Weick, MD, Frederick R. Appelbaum, MD, Harry P. Erba, MD PhD, Elihu H. Estey, MD

Blood (2019) 134 (Supplement_1): 291.

https://doi.org/10.1182/blood-2019-127356

Published: 2019

Journal Articles

The MAGIC Algorithm Probability (MAP): A Novel Laboratory Biomarker for the Response to Treatment of Acute Graft-Versus-Host Disease

Blood (2019) 134 (Supplement_1): 367.

https://doi.org/10.1182/blood-2019-122011

Published: 2019

Journal Articles

In Vivo reconstruction of Human Erythropoiesis with Circulating Mature Human RBCs in Humanized Liver Mistrg Mice

Yuanbin Song, MD, Liang Shan, PhD, Rana Gbyli, MS, Wei Liu, PhD, Xiaoying Fu, MD, Xiaman Wang, MD PhD, Ashley Qin, Amisha Patel, MS, Yimeng Gao, PhD, Toma Tebaldi, PhD, Giulia Biancon, PhD, David Urbonas, Jonathan Alderman, PhD, Stephanie Halene, MD, Richard Flavell, PhD

Blood (2019) 134 (Supplement_1): 338.

https://doi.org/10.1182/blood-2019-130701

Published: 2019

Journal Articles

Circulating Tumor DNA in the Peripheral Blood As Early Predictor of Clinical Outcome in Relapsed/ Refractory Multiple Myeloma

Blood (2019) 134 (Supplement_1): 4350.

https://doi.org/10.1182/blood-2019-131037

Published: 2019

NARROW

Losing control to bad relatives

Molecular bases for the association of FHR-1 with atypical hemolytic uremic syndrome and other diseases

Markers of complement activation in plasma during quiescent phases in patients with catastrophic antiphospholipid syndrome

Eculizumab discontinuation in children and adults with atypical hemolytic-uremic syndrome: a prospective multicenter study

How I treat cold agglutinin disease

How I treat paroxysmal nocturnal hemoglobinuria

More about complement in the antiphospholipid syndrome

The different flavors and splices of MCL

Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab

Compliments to complement blockade for TA-TMA

A complementary new drug for PNH

The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria

“HIT”ing back against NETs

Taken the wrong way, a complement becomes catastrophic

Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study

Increasing Lengths of First Complete Remission with 7+3 Induction Chemotherapy for Acute Myeloid Leukemia over the Past Four Decades: Analysis of SWOG Trial Data

The MAGIC Algorithm Probability (MAP): A Novel Laboratory Biomarker for the Response to Treatment of Acute Graft-Versus-Host Disease

In Vivo reconstruction of Human Erythropoiesis with Circulating Mature Human RBCs in Humanized Liver Mistrg Mice

Circulating Tumor DNA in the Peripheral Blood As Early Predictor of Clinical Outcome in Relapsed/ Refractory Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only